FiercePharma8h
In PAHO-backed access initiative, Argentina's Sinergium Biotech to locally produce Pfizer's Prevnar 20
Pfizer’s latest-generation pneumococcal conjugate vaccine is in line to reach more people in Latin America and the Caribbean ...
Things You Probably Don't Know About Viagra (Like What It Was Originally Used For)
Whether you’re a senior in high school or a senior-living resident, you’ve likely heard of Viagra (sildenafil) — the original ...
Why Pfizer sold its $3 billion stake in Haleon
Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
Pfizer is looking to sell about 700 million ordinary shares in Haleon , its bookrunner J.P. Morgan said on Tuesday, lowering ...
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion
The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...
Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund
Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...
Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges
Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...
Aspargo Labs Aims For Direct Listing On Little Revenue
Aspargo Labs aims for a direct listing despite minimal revenue, significant losses, and high cash burn. Click here to read an ...
Zacks.com on MSN3d
Pfizer Meets Goal in Non-Muscle Invasive Bladder Cancer Study
Pfizer PFE announced positive results from the phase III CREST study that evaluated its investigational PD-1 inhibitor sasanlimab in patients with BCG-naïve, high-risk, non-muscle invasive bladder ...